In this large, population-based study, Xie et al. found that the risks of SARS-CoV-2 infection, 30-day hospitalization and 30-day death were higher among individuals with gout than individuals without gout in the general population, irrespective of COVID-19 vaccination status.
Search results for: gout
Considering Benzbromarone as First-Line Therapy for Gout
In this comparative effectiveness clinical trial, Yan et al. set out to compare nontitrated, low-dose benzbromarone (not approved in the U.S.), a renal urate transporter 1 inhibitor, with low-dose febuxostat as the first-line therapy in gout patients with renal uric acid underexcretion.
![](https://www.the-rheumatologist.org/wp-content/uploads/2022/11/Charles-Dinarello-150x150.jpg)
Is Gout an Autoinflammatory Syndrome After All?
PHILADELPHIA—The term autoinflammatory syndrome was coined by Daniel L. Kastner, MD, PhD, National Institutes of Health (NIH), Bethesda, Md., not long after he discovered that mutations in the gene MEFV, which codes for the protein pyrin, are responsible for familial Mediterranean fever (FMF).1 Early on, the term was meant to signify monogenic conditions in which…
![](https://www.the-rheumatologist.org/wp-content/uploads/2022/11/08-14-0074-150x150.jpg)
Gout Research at a Glance
PHILADELPHIA—Approximately 60 research abstracts on gout were accepted for presentation at ACR Convergence 2022, including two plenary abstract presentations. It is exciting to see a wealth of research on gout being undertaken worldwide. Here, we highlight important points from seven of these studies. 1. Abstract 1810: Frequency and Patterns of Opioid Use in the Management…
![](https://www.the-rheumatologist.org/wp-content/uploads/2022/11/LSCMYNVU-Presenter-BotsonJ-150x150.jpg)
Options for Refractory Gout, ILD & More
PHILADELPHIA—At the first Plenary Session of ACR Convergence 2022, on Saturday, Nov. 12, speakers shared key research findings on the efficacy and safety of methotrexate as a co-therapy with pegloticase in refractory gout, the effectiveness of rituximab and cyclophosphamide in connective tissue disease associated-interstitial lung disease and the value of remote education for primary care…
![gout magnifying glass image](https://www.the-rheumatologist.org/wp-content/uploads/2020/11/goutmagnifyingglassart-150x150.jpg)
Gout: What Diet Affects Incidence?
![](https://www.the-rheumatologist.org/wp-content/uploads/2015/05/Science_Research_500x270-150x150.gif)
Gout: Treat to Target
Top Research in Gout Presented at ACR Convergence 2022
With ~60 research abstracts on gout accepted for presentation at ACR Convergence 2022, filtering the noise to get to the key thoughts may be challenging. Lisa Stamp, MBChB, PhD, can help. A rheumatologist, professor of medicine and the associate dean of research at the University of Otago in Christchurch, New Zealand, she has extensively researched…
Gout Is an Autoinflammatory Metabolic Disease
On Monday, Nov. 14, Michael Pillinger, MD, will moderate the session Gout Is an Autoinflammatory Metabolic Disease at ACR Convergence 2022. This session will address the autoinflammatory nature of gout and highlight it as an IL-1β-mediated diseases. Increasing knowledge on the inflammatory mechanisms of gout has implications for disease management. These engaging talks will review…
![The Why & What of the ACR's Clinical Practice Guidelines](https://www.the-rheumatologist.org/wp-content/uploads/2018/02/THR_0218_pg60a-150x150.png)
Gout: Prophylaxis with ULT
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 57
- Next Page »